Published in J Virol on March 01, 1999
Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors. J Virol (2006) 3.63
Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity. J Virol (2001) 2.16
Cytoplasmic viral replication complexes. Cell Host Microbe (2010) 2.09
Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev (2001) 2.08
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84
A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol (2001) 1.80
Improved primate foamy virus vectors and packaging constructs. J Virol (2002) 1.65
Nucleocapsid protein function in early infection processes. Virus Res (2008) 1.53
Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol (2006) 1.52
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J (2001) 1.47
Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol (2004) 1.44
Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog (2011) 1.39
Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol (2001) 1.38
HIV infection of non-dividing cells: a divisive problem. Retrovirology (2006) 1.33
Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci U S A (2002) 1.32
Isolation and characterization of an equine foamy virus. J Virol (2000) 1.30
Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J Virol (2004) 1.30
Feline foamy virus genome and replication strategy. J Virol (2003) 1.25
Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol (2001) 1.24
Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol (2006) 1.23
An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol (2000) 1.23
Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J Virol (2002) 1.22
Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging. J Virol (2000) 1.18
Molecular biology of foamy viruses. Med Microbiol Immunol (2010) 1.16
Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J Virol (2003) 1.16
Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol (2000) 1.14
The intact retroviral Env glycoprotein of human foamy virus is a trimer. J Virol (2000) 1.13
Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J Biol Chem (2008) 1.12
Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J (2000) 1.11
TVB receptors for cytopathic and noncytopathic subgroups of avian leukosis viruses are functional death receptors. J Virol (2000) 1.10
Identification of domains in gag important for prototypic foamy virus egress. J Virol (2005) 1.09
Features, processing states, and heterologous protein interactions in the modulation of the retroviral nucleocapsid protein function. RNA Biol (2010) 1.08
Biphasic DNA synthesis in spumaviruses. J Virol (2003) 1.08
Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J Virol (2008) 1.05
Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol (2001) 1.05
Regulation of foamy virus protease activity by viral RNA: a novel and unique mechanism among retroviruses. J Virol (2011) 1.03
Genetic stability of foamy viruses: long-term study in an African green monkey population. J Virol (1999) 1.03
Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses. J Virol (2011) 1.03
Role of the foamy virus Pol cleavage site in viral replication. J Virol (2007) 1.00
The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome. PLoS Pathog (2011) 1.00
Effects of homology length in the repeat region on minus-strand DNA transfer and retroviral replication. J Virol (2001) 1.00
Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. J Virol (1999) 0.99
IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J Virol (2008) 0.98
Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells. J Virol (2000) 0.97
Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo. J Virol (2001) 0.95
Interaction of the cauliflower mosaic virus coat protein with the pregenomic RNA leader. J Virol (2000) 0.95
N-terminal Gag domain required for foamy virus particle assembly and export. J Virol (2005) 0.94
The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression. J Virol (2001) 0.93
Foamy virus envelope glycoprotein is sufficient for particle budding and release. J Virol (2003) 0.93
Discovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolution. Retrovirology (2014) 0.91
Deoxynucleoside triphosphate incorporation mechanism of foamy virus (FV) reverse transcriptase: implications for cell tropism of FV. J Virol (2008) 0.90
Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particles. Retrovirology (2012) 0.89
The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res (2008) 0.89
Evolution of foamy viruses: the most ancient of all retroviruses. Viruses (2013) 0.89
Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism. J Virol (2004) 0.89
Palindromic sequence plays a critical role in human foamy virus dimerization. J Virol (2001) 0.88
Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission. Viruses (2013) 0.87
Innate sensing of foamy viruses by human hematopoietic cells. J Virol (2011) 0.87
Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J Virol (2002) 0.87
Converging strategies in expression of human complex retroviruses. Viruses (2011) 0.86
Nuclear trafficking of retroviral RNAs and Gag proteins during late steps of replication. Viruses (2013) 0.85
The foamy virus Gag proteins: what makes them different? Viruses (2013) 0.85
C3H mouse mammary tumor virus superantigen function requires a splice donor site in the envelope gene. J Virol (2000) 0.85
Molecular dissection of the prototype foamy virus (PFV) RNA 5'-UTR identifies essential elements of a ribosomal shunt. Nucleic Acids Res (2009) 0.83
Foamy virus integration. J Virol (2004) 0.83
Foamy virus assembly with emphasis on pol encapsidation. Viruses (2013) 0.82
Structural and evolutionary analysis of an orangutan foamy virus. J Virol (2003) 0.82
Genomic flexibility of human endogenous retrovirus type K. J Virol (2014) 0.81
The promyelocytic leukemia protein does not mediate foamy virus latency in vitro. J Virol (2003) 0.80
N-Myc interactor inhibits prototype foamy virus by sequestering viral Tas protein in the cytoplasm. J Virol (2014) 0.80
Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats. J Virol (2003) 0.80
Wide distribution and ancient evolutionary history of simian foamy viruses in New World primates. Retrovirology (2015) 0.80
N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles. Viruses (2011) 0.79
Human Pirh2 is a novel inhibitor of prototype foamy virus replication. Viruses (2015) 0.78
Horizontal acquisition and a broad biodistribution typify simian foamy virus infection in a cohort of Macaca fascicularis. Virol J (2013) 0.78
Nuclear localization signals in prototype foamy viral integrase for successive infection and replication in dividing cells. Mol Cells (2014) 0.77
Replication-competent hybrids between murine leukemia virus and foamy virus. J Virol (2003) 0.76
Relative Comparison of Catalytic Characteristics of Human Foamy Virus and HIV-1 Integrases. Acta Naturae (2009) 0.76
Retroviral DNA Transposition: Themes and Variations. Microbiol Spectr (2014) 0.76
Structural studies of the catalytic core of the primate foamy virus (PFV-1) integrase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.76
Structural and functional insights into foamy viral integrase. Viruses (2013) 0.76
Evolutionary Relationships among Extinct and Extant Sloths: The Evidence of Mitogenomes and Retroviruses. Genome Biol Evol (2016) 0.75
Acquisition and processing of nonhuman primate samples for genetic and phylogenetic analyses. Methods (2009) 0.75
Effect of fetal bovine serum on foamy and lentiviral vector production. Hum Gene Ther Methods (2013) 0.75
Further Evidence that Human Endogenous Retrovirus K102 is a Replication Competent Foamy Virus that may Antagonize HIV-1 Replication. Open AIDS J (2015) 0.75
The polyprotein gag of retroelement gypsy can form multimeric complexes when expressed in bacterial system. Dokl Biochem Biophys (2001) 0.75
An expanded search for simian foamy viruses (SFV) in Brazilian New World primates identifies novel SFV lineages and host age-related infections. Retrovirology (2015) 0.75
Foamy-like endogenous retroviruses are extensive and abundant in teleosts. Virus Evol (2016) 0.75
Complete Genome Sequences of Two Novel Puma concolor Foamy Viruses from California. Genome Announc (2013) 0.75
Form, function, and use of retroviral gag proteins. AIDS (1991) 9.24
Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med (1954) 9.02
RNA packaging. Curr Top Microbiol Immunol (1996) 4.88
Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J Virol (1992) 4.72
An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst (1971) 3.30
Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol (1988) 3.28
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science (1996) 3.25
Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J (1987) 2.87
Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology (1991) 2.70
The foamy viruses. Bacteriol Rev (1975) 2.53
Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol (1991) 2.51
RNA- and DNA-binding activities in hepatitis B virus capsid protein: a model for their roles in viral replication. J Virol (1992) 2.42
Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol (1997) 2.42
Nuclear localization of foamy virus Gag precursor protein. J Virol (1994) 2.36
Foamy virus capsids require the cognate envelope protein for particle export. J Virol (1999) 2.30
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A (1993) 2.30
Retroviral diversity and distribution in vertebrates. J Virol (1998) 2.22
Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A (1996) 2.22
Foamy virus particle formation. J Virol (1998) 2.22
The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor? J Virol (1996) 2.21
Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol (1993) 2.18
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology (1994) 1.94
Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses (1995) 1.92
The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol (1996) 1.91
Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J Virol (1997) 1.90
A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J Virol (1997) 1.85
Evidence that the human foamy virus genome is DNA. J Virol (1999) 1.85
The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol (1998) 1.82
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol (1995) 1.81
The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol (1996) 1.74
Foamy virus vectors. J Virol (1996) 1.72
Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res (1988) 1.71
Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J Virol (1998) 1.67
Infectious DNA of the human spumaretrovirus. Nucleic Acids Res (1990) 1.67
Spumaviruses: a group of complex retroviruses. J Acquir Immune Defic Syndr (1991) 1.64
Isolation of novel human endogenous retrovirus-like elements with foamy virus-related pol sequence. J Virol (1995) 1.62
Identification of the major immunogenic structural proteins of human foamy virus. J Gen Virol (1990) 1.60
Functional analysis of human foamy virus accessory reading frames. J Virol (1993) 1.59
Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J Virol (1997) 1.57
Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain. J Virol (1996) 1.46
Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol (1998) 1.46
Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA. Virology (1996) 1.41
Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol (1994) 1.40
A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology (1995) 1.37
Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol (1996) 1.35
Expression and maturation of human foamy virus Gag precursor polypeptides. J Virol (1997) 1.33
Characterization of new simian foamy viruses from African nonhuman primates. Virology (1997) 1.33
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J Virol (1997) 1.32
A defective human foamy provirus generated by pregenome splicing. EMBO J (1993) 1.29
The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology (1998) 1.26
Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease. J Virol (1998) 1.24
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol (1993) 1.24
The human foamy virus internal promoter is required for efficient gene expression and infectivity. Virology (1995) 1.23
The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J Virol (1996) 1.22
An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection. J Virol (1998) 1.19
Molecular biological characterization of the human foamy virus reverse transcriptase and ribonuclease H domains. Virology (1995) 1.18
Involvement of a spliced and defective human foamy virus in the establishment of chronic infection. J Virol (1995) 1.16
Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection. Virology (1998) 1.16
Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol (1998) 1.15
Foamy viruses. Intervirology (1993) 1.15
No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses (1996) 1.13
Productive persistent infection of hematopoietic cells by human foamy virus. J Virol (1996) 1.12
Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology (1995) 1.09
Long-term persistent infection of domestic rabbits by the human foamy virus. Virology (1997) 1.06
Characterization of the internal promoter of simian foamy viruses. J Virol (1994) 1.06
Protein composition and morphology of human foamy virus intracellular cores and extracellular particles. Virology (1997) 1.05
Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses (1998) 1.05
Long terminal repeat U3 length polymorphism of human foamy virus. Virology (1997) 1.04
Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene. Virology (1994) 1.02
Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. J Virol (1998) 1.02
Expression and molecular characterization of an enzymatically active recombinant human spumaretrovirus protease. Biochem Biophys Res Commun (1997) 1.02
Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1. J Biol Chem (1995) 1.00
Mouse model to study the replication of primate foamy viruses. J Gen Virol (1997) 1.00
The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus. J Virol (1998) 0.97
Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class. J Virol (1994) 0.97
The simian foamy virus type 1 transcriptional transactivator (Tas) binds and activates an enhancer element in the gag gene. J Virol (1996) 0.97
Foamy virus vectors for suicide gene therapy. Gene Ther (1997) 0.97
Detection and characterization of infectious DNA intermediates of a primary foamy virus. J Gen Virol (1986) 0.96
Structural analysis of proviral DNA in simian foamy virus (LK-3)-infected cells. Arch Virol (1989) 0.95
The gene expression of human foamy virus does not require a post-transcriptional transactivator. Virology (1994) 0.95
Biochemical properties of a hamster syncytium-forming ("foamy") virus. J Natl Cancer Inst (1975) 0.86
Isolation of a retrovirus and a herpesvirus from a captive California sea lion. J Wildl Dis (1986) 0.86
Serological survey of the Iriomote cat (Felis iriomotensis) in Japan. J Wildl Dis (1990) 0.84
Regulation of gene expression by human foamy virus and potentials of foamy viral vectors. Stem Cells (1997) 0.84
Feline retroviruses: a brief review. Vet Microbiol (1990) 0.82
Isolations and serology of bovine spumavirus. Aust Vet J (1983) 0.82
Deletion analysis of both the long terminal repeat and the internal promoters of the human foamy virus. Virus Genes (1997) 0.81
Detection of immunological tolerance to bovine spumavirus (BSV) with evidence for salivary excretion and spread of BSV from the tolerant animal. Vet Microbiol (1988) 0.80